Neuroendocrine Tumors

Lu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET)

Efficacy and Safety of 177Lu-edotreotide PRRT in GEP-NET Patients

The Use of Guarana to Treat Fatigue in Patients With Neuroendocrine Tumors and Gynecologic Cancers (Guarana Fatigue)

Follow Up Protocol for Subjects Previously Enrolled on NCI Surgery Branch Studies

TARGETed Therapy Drug MONITOring in DIGestive Oncology

A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors

Comparing DLL3 PET/CT to Standard Scans in Neuroendocrine Cancer

Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors

An Open, Single-center Clinical Study of Surufatinib Combined With Temozolomide and S-1 in the First-line Treatment of Advanced Neuroendocrine Tumors

Defining Response Criteria for PET Scans for People With Neuroendocrine Tumors

Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types

Study of CTX-471 in Patients With Neural Cell Adhesion Molecule (NCAM) Positive Neuroendocrine Neoplasms

Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer

Study of Cabozantinib in Participants With Neuroendocrine Tumors Who Have Already Received Prior Treatment

Integrated Cancer Repository for Cancer Research

Safety, Tolerability and Preliminary Efficacy of NEUK203-13 in Refractory Neuroendocrine Tumor Patients

Using Novel Imaging to More Safely Treat Neuroendocrine Tumors

211At-MABG in Adults With Advanced Neuroendocrine Cancers

A First-in-Human Phase I Trial With Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors, Carcinomas and Malignant Peripheral Nerve Sheath Tumors

Lipiodol Deposition Using Endhole vs. Pressure-Modulated Delivery